Login to Your Account



PDUFA Date: Oct. 30

Transcept Strikes Up $145M Purdue Deal for Intermezzo

By Jennifer Boggs


Tuesday, August 4, 2009
Just three months ahead of the FDA's action date for Intermezzo, Transcept Pharmaceuticals Inc. secured a potential $145 million partnership with Purdue Pharmaceutical Products LP, a deal that pads the firm's already solid cash balance and sets the stage for Transcept to build its own specialty sales force. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription